Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022

SELL
$126.46 - $235.05 $833,750 - $1.55 Million
-6,593 Closed
0 $0
Q4 2021

Jan 19, 2022

SELL
$225.82 - $368.51 $366,505 - $598,091
-1,623 Reduced 19.75%
6,593 $1.67 Million
Q3 2021

Oct 14, 2021

SELL
$221.9 - $484.47 $25,740 - $56,198
-116 Reduced 1.39%
8,216 $3.16 Million
Q2 2021

Jul 22, 2021

SELL
$129.91 - $234.98 $35,205 - $63,679
-271 Reduced 3.15%
8,332 $1.96 Million
Q1 2021

May 12, 2021

BUY
$109.18 - $185.98 $569,919 - $970,815
5,220 Added 154.3%
8,603 $1.13 Million
Q4 2020

Feb 23, 2021

BUY
$65.74 - $169.86 $222,398 - $574,636
3,383 New
3,383 $353,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Purus Wealth Management, LLC Portfolio

Follow Purus Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Purus Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Purus Wealth Management, LLC with notifications on news.